FindTrial
Sign In

REDUCE THE LOW WEIGHT WHEN BORN IN ENDEMIC AREAS OF UNCINARIASIS: A RANDOMIZED CLINICAL TRIAL OF IRON SUPPLEMENT VS. IRON SUPPLEMENT WITH MEBENDAZOLE

REDUCE THE LOW WEIGHT WHEN BORN IN ENDEMIC AREAS OF UNCINARIASIS: A RANDOMIZED CLINICAL TRIAL OF IRON SUPPLEMENT VS. IRON SUPPLEMENT WITH MEBENDAZOLE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-070-02
Enrollment
Unknown
Registered
2002-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Mebendazole Type of group
a dose of mebendazole (500 mg) during the second trimester to an iron supplement daily on the average birth weight of the babies will be studied.

Sponsors

UNIVERSIDAD PERUANA CAYETANO HEREDIA,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Being in the second trimester of pregnancy, being between 18 and 44 years of age, not having received anti-helminthic treatment in the last 6 months, coming from rural areas and / or not having water and sewage in their homes and finally, giving consent to participate in the study.

Exclusion criteria

Exclusion criteria: Women with severe anemia (Hb <80 g / 1) will be excluded from the study and will be referred for medical treatment and women who have a medical condition that needs constant follow-up will be excluded.

Design outcomes

Primary

MeasureTime frame
Outcome name:not contemplated Measure:not contemplated Timepoints:not contemplated—

Secondary

MeasureTime frame
Outcome name:not contemplated Measure:not contemplated Timepoints:not contemplated—

Countries

Peru

Outcome results

None listed

Source: REPEC (via WHO ICTRP)